πŸ‡ΊπŸ‡Έ FDA
Patent

US 9603829

HSP90 inhibitors with modified toxicity

granted A61KA61K31/337A61K31/395

Quick answer

US patent 9603829 (HSP90 inhibitors with modified toxicity) held by The Regents of the University of Colorado, a Body Corporate expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/337, A61K31/395, A61K31/4427, A61K31/704